How to Reconstitute BPC-157 and TB-500: Step-by-Step Supplies Guide

Australian regulatory note: BPC-157 and TB-500 are not TGA-approved for human therapeutic use in Australia and are generally supplied for laboratory or research purposes. This guide explains the mechanical process of reconstitution and the equipment involved; it is not an endorsement or instruction to self-administer.

BPC-157 and TB-500 are two commonly discussed research peptides, and they often arrive the same way: a small amount of white, freeze-dried (lyophilised) powder sealed in a glass vial. Only material supplied as sterile/pyrogen-free and suitable for the validated protocol should be handled for any administration pathway; adding sterile or bacteriostatic water does not make research-grade powder sterile or injectable. Before suitable material can be measured or drawn into a syringe in any validated protocol, it may need to be reconstituted with the specified sterile diluent. This guide covers supplies, handling mechanics, concentration arithmetic for common vial sizes, and storage caveats.

For the complete, general step-by-step (with photos of each stage) see our full peptide reconstitution guide. This article focuses on what's specific to the BPC-157 and TB-500 pair.

Should you reconstitute them in the same vial?

The most common question with this pairing is whether both powders can be reconstituted into one vial. Compatibility and stability data for user-mixed BPC-157/TB-500 blends are limited or absent, and a commercial pre-blended product does not validate a user-made blend. Do not assume a combined vial is usable unless it is part of a validated protocol. For any pre-blended product, follow the supplied written instructions only where the material is sterile/pyrogen-free, lawful for the intended context, and suitable for that validated or prescribed protocol.

For general handling, reconstituting and storing each in its own labelled vial is the more conservative approach:

• Dose precision. Separate vials let you set each peptide's concentration independently and adjust one without touching the other. A blend locks you into whatever ratio was mixed.
• Fewer variables. Separate vials make protocol changes easier to track, but they do not prove which compound caused an observed change.
• Shelf life. The two can have different stability profiles, so a shared vial forces one compromise expiry date instead of tracking each on its own.

This guide does not advise whether either product should be administered or combined. For contamination control, a fresh sterile transfer syringe may draw diluent from the diluent vial and inject it into one peptide vial as a one-way transfer, then must be discarded. It must never return to the diluent vial, touch a person, or enter another peptide or stock vial. For withdrawals from any reconstituted or multi-dose stock vial, use a new sterile syringe/needle each time, and never re-enter any vial with a syringe or needle that has touched a person or any non-sterile surface. Changing only a detachable needle does not remove contamination risk from the syringe hub, barrel or fluid path unless a validated protocol says otherwise. Follow a licensed clinician's instructions or a validated laboratory protocol for any administration or blending decision.

Supplies you'll need

Per peptide vial you're reconstituting:

• The lyophilised peptide vial (BPC-157 or TB-500)
• Bacteriostatic water (10mL vial) - only when the supplier instructions, prescriber or validated protocol specifies it; see the note below
• A sterile syringe or validated sterile transfer device for moving the specified diluent into the peptide vial. A separate drawing-up needle may be convenient for larger volumes, but is not the only sterile transfer option; see the note below
• 0.5mL insulin syringes (31G) or 1mL insulin syringes (31G) for small-volume measurement when compatible with the specified route and protocol
• Alcohol prep wipes for vial stoppers. For prescribed administration, follow the clinician's injection-site preparation instructions.
• A sharps container for safe disposal

One 10mL vial of bacteriostatic water may supply several reconstitutions only if the label permits repeated withdrawals, the after-opening period or beyond-use date has not passed, aseptic technique is maintained, and a new sterile syringe/needle is used for every withdrawal.

The draw needle is convenient, not essential. A wider-bore sterile draw needle can reduce draw resistance and fill faster when paired with a syringe large enough for the intended volume. A sterile 10 mL syringe fitted with an 18G draw needle can be appropriate for larger one-way transfer volumes when written instructions allow that gauge. Use it for draw/transfer only, keep punctures to a minimum, and ask your pharmacist or protocol owner if a different transfer device is required for small vials or repeated access to reduce stopper damage or coring. For a one-way 1mL diluent transfer, a new sterile 1mL insulin syringe can move diluent from the diluent vial into one peptide vial and then be discarded. Need 2mL? Use two completely new sterile 1mL syringes, or preferably one sterile larger-volume syringe with a detachable sterile needle. Never return a syringe or needle that has entered a peptide vial to the diluent vial, and never use it to enter any second peptide vial; use a new sterile syringe/needle or validated transfer device for each stock vial.

How much water to add (5mg and 10mg vials)

The amount of bacteriostatic water you add doesn't change how much peptide is in the vial - it only changes the concentration, which in turn changes how many units you draw on the syringe. The formula is simple:

For these arithmetic examples, assuming the final volume is effectively the diluent volume added: concentration (mg/mL) = peptide mass in the vial (mg) divided by final or reconstituted volume (mL).

BPC-157 and TB-500 are most often sold in 5mg and 10mg vials. On a U-100 insulin syringe, 1 "unit" = 0.01mL, so 100 units = 1mL. Here's how common water volumes work out:

A larger water volume spreads the same peptide over more units on the syringe, which can make small amounts easier to measure accurately. When a prescriber, supplier instruction, or validated protocol specifies the amount, confirm a diluent volume that gives a measurable syringe volume; the examples are arithmetic only, not dosing advice. To turn a concentration into syringe units for a given amount, our dose volume calculator does the arithmetic, and our guide to reading an insulin syringe explains units vs millilitres.

The mixing technique

The technique is the same for both peptides. Do each vial one at a time:

1. Bring both vials to room temperature and wipe each rubber stopper with its own fresh alcohol wipe; let each stopper air-dry before puncturing.
2. Draw the specified diluent volume into your syringe - the drawing-up needle if you have one, or a new sterile 1mL insulin syringe for small one-way transfers.
3. Add the water slowly down the inside wall of the peptide vial - aim the needle at the glass, not directly at the powder. Avoid forcefully spraying the powder because it can cause foaming or agitation and may affect fragile peptides.
4. Do not shake. Gently swirl the vial or roll it between your palms until the powder fully dissolves. Dissolution time differs between products: BPC-157 may go clear quickly, while TB-500, a thymosin beta-4-related peptide, can be slower and may need longer gentle swirling - don't assume a vial has failed just because it is not clear after a minute. Persistent cloudiness or visible particles after the expected full dissolution time, or any appearance change during storage, is a reason to discard; clarity does not prove sterility or suitability.
5. Label the vial with the peptide name, the concentration, and the date you reconstituted it.

For the same steps with detailed photos, see the full reconstitution guide.

Why bacteriostatic water may be specified

Bacteriostatic water commonly contains 0.9% benzyl alcohol; check the product label and use only the diluent specified by the supplier instructions, prescriber or validated protocol. The preservative helps inhibit microbial growth during repeated withdrawals when strict aseptic technique is used, but it does not sterilise a contaminated vial or make poor technique safe. Preservative-free sterile water or preservative-free saline may be specified for some products or single-use protocols; they lack preservative and should not be repeatedly punctured after opening. There's more detail in our reconstitution guide.

Storage and shelf life

Before reconstitution, lyophilised BPC-157 and TB-500 should be stored according to the manufacturer label, pharmacy instructions or validated protocol. Once reconstituted:

• Unless the label, pharmacist, or validated protocol says otherwise, refrigerate at 2-8°C. Do not freeze or thaw repeatedly unless the product instructions specifically allow it.
• Follow the labelled or protocol beyond-use date. Some manufactured multi-dose vial workflows use 28 days as an upper-limit handling convention, but this is not a default shelf life for reconstituted peptides. Use the shortest labelled, pharmacist, prescriber, or validated-protocol beyond-use date, and discard sooner if the solution turns cloudy, changes appearance, or sterility is uncertain.
• Keep it labelled with the date and concentration so two vials in the fridge never get confused - easy to do when you're reconstituting two peptides at once.

Common issues and what to do

• Combined two powders into one vial without a validated protocol. Accurate amounts alone do not establish sterility, compatibility, potency or stability. Do not assume the vial is usable; discard and start over with separately labelled vials unless the mixture is part of a validated protocol.
• Solution stayed cloudy. If cloudiness or particles persist after the expected full dissolution time, or the solution changes appearance during storage, discard it. Clear appearance is expected for many products but does not confirm sterility or potency.
• Lost track of which vial is which. This is why the labelling step matters - two unlabelled clear vials are indistinguishable. If in doubt, discard.
• Diluent sprayed onto the powder and it foamed. Letting foam settle only addresses appearance. Follow supplier or protocol instructions and discard if stability or potency is uncertain, foam or cloudiness persists, or the solution changes appearance. Next time, aim the stream at the vial wall.

Frequently asked questions

Can I reconstitute BPC-157 and TB-500 in the same vial?

Do not assume a user-mixed blend is usable unless it is part of a validated protocol. For any pre-blended product, follow the supplied written instructions only where the material is sterile/pyrogen-free, lawful for the intended context, and suitable for that validated or prescribed protocol. Compatibility and stability data for user-mixed blends are limited or absent. For contamination control, a new sterile syringe may be used for a one-way transfer from the diluent vial into one target peptide vial, then discarded. It must not return to the diluent or source vial or enter any additional peptide, stock, or multi-dose vial. This applies to fixed-needle insulin syringes and detachable-needle syringes where only the needle is changed.

How much bacteriostatic water should I add to a 5mg or 10mg vial?

There's no single "correct" volume - it sets the concentration. Use the diluent volume specified by the supplier instructions, prescriber, pharmacist, or validated protocol. Where a protocol permits a choice, choose a volume that gives a measurable syringe volume; the table is arithmetic only, not a recommended amount.

How long does reconstituted BPC-157 or TB-500 last?

Follow the supplier, manufacturer, prescriber, pharmacist or validated-protocol beyond-use date. A 28-day convention in some multi-dose vial workflows is not a default shelf life for reconstituted peptides and does not prove chemical stability, potency or suitability.

Tip: a vial storage case keeps vials upright, cushioned and organised. Travel storage must maintain the labelled or protocol temperature range, avoid freezing, and should not rely on a plain case if refrigeration is required.

What size syringe do I need?

A sterile syringe and appropriate draw needle are used to add the specified diluent. A fine 0.5mL or 1mL insulin syringe (31G) may be suitable for small-volume measurement when compatible with the prescribed route and protocol; the 0.5mL barrel is easier to read for small amounts.

Get your reconstitution supplies

We stock everything on the supplies list above - bacteriostatic water, syringes and draw needles, alcohol wipes, and sharps containers - shipped fast in plain, discreet packaging across Australia. Browse the reconstitution supplies collection to get sorted in one order.